✦ LIBER ✦

Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia

✍ Scribed by Rassenti, L; Kipps, T J; Castro, J E; James, D F; Sandoval-Sus, J D; Jain, S; Bole, J

Book ID: 109886987
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 23
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2009.232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab in combination with high-dose

Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia

✍ Castro, J E; James, D F; Sandoval-Sus, J D; Jain, S; Bole, J; Rassenti, L; Kipps 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 412 KB

Rituximab in combination with high-dose

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia

✍ Castro, J E; Sandoval-Sus, J D; Bole, J; Rassenti, L; Kipps, T J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

Serum globulins as marker of immune rest

Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia

✍ Doru T. Alexandrescu; Peter H. Wiernik 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 324 KB

Early treatment of high-risk chronic lym

Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab

✍ Clive S. Zent; Timothy G. Call; Tait D. Shanafelt; Renee C. Tschumper; Diane F. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract ## BACKGROUND. Patients with chronic lymphocytic leukemia (CLL) usually are treated only for progressive disease. However, the discovery of biologic predictors of a high risk of disease progression, together with the development of newer, more targeted therapies, could change this para

Effective treatment of leukemia cutis wi

Effective treatment of leukemia cutis with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia

✍ Aleksandra Batycka-Baran; Wojciech Baran; Justyna Dzietczenia; Grzegorz Mazur 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 138 KB

Rituximab–cyclophosphamide–dexamethasone

Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia

✍ Rossignol, J; Michallet, A-S; Oberic, L; Picard, M; Garon, A; Willekens, C; Dule 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 415 KB